Controversies in primary treatment of low-risk papillary thyroid cancer

DSA McLeod, AM Sawka, DS Cooper - The Lancet, 2013 - thelancet.com
In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …

[引用][C] Controversies in primary treatment of low-risk papillary thyroid cancer

DSA MCLEOD, AM SAWKA… - Lancet (British …, 2013 - pascal-francis.inist.fr
Controversies in primary treatment of low-risk papillary thyroid cancer CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

[引用][C] Controversies in primary treatment of low-risk papillary thyroid cancer

DSA McLeod, AM Sawka, DS Cooper - The Lancet, 2013 - cir.nii.ac.jp
Controversies in primary treatment of low-risk papillary thyroid cancer | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Controversies in primary treatment of low-risk papillary thyroid cancer

DSA McLeod, AM Sawka, DS Cooper - The Lancet, 2013 - Elsevier
In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …

Controversies in primary treatment of low-risk papillary thyroid cancer

DSA McLeod, AM Sawka, DS Cooper - The Lancet, 2013 - thelancet.com
In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …

Controversies in primary treatment of low-risk papillary thyroid cancer

DSA McLeod, AM Sawka, DS Cooper - The Lancet, 2013 - pure.johnshopkins.edu
In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …

Controversies in primary treatment of low-risk papillary thyroid cancer

DSA Mcleod, AM Sawka, DS Cooper - The Lancet, 2013 - hero.epa.gov
In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …

Controversies in primary treatment of low-risk papillary thyroid cancer.

DS McLeod, AM Sawka, DS Cooper - Lancet (London, England), 2013 - europepmc.org
Controversies in primary treatment of low-risk papillary thyroid cancer. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Controversies in primary treatment of low-risk papillary thyroid cancer

DSA McLeod, AM Sawka… - Lancet (London …, 2013 - pubmed.ncbi.nlm.nih.gov
In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …

Controversies in primary treatment of low-risk papillary thyroid cancer

DSA McLeod, AM Sawka, DS Cooper - The Lancet, 2013 - infona.pl
In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …